Greenwood Capital Associates LLC Has $5.01 Million Stake in Danaher Corporation $DHR

Key Points

• Greenwood Capital Associates LLC boosted its stake in Danaher by 420.2% in Q4 to 21,894 shares, valued at about $5.01 million.
• Danaher beat quarterly expectations with $2.23 EPS (vs. $2.14) and $6.84B revenue (up 4.6% YoY), and raised its quarterly dividend to $0.40 (annualized $1.60, ~0.8% yield).
• Analysts hold a consensus Moderate Buy on DHR with an average target of $247.35 (18 Buys, 3 Holds), and institutional investors own roughly 79% of the shares.

Greenwood Capital Associates LLC increased its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 420.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 21,894 shares of the conglomerate's stock after acquiring an additional 17,685 shares during the period. Greenwood Capital Associates LLC's holdings in Danaher were worth $5,012,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. JPL Wealth Management LLC acquired a new position in shares of Danaher during the 3rd quarter valued at about $25,000. WFA of San Diego LLC acquired a new position in shares of Danaher during the 2nd quarter valued at about $26,000. ANTIPODES PARTNERS Ltd acquired a new position in shares of Danaher during the 3rd quarter valued at about $27,000. TruNorth Capital Management LLC acquired a new position in shares of Danaher during the 3rd quarter valued at about $28,000. Finally, Tripletail Wealth Management LLC acquired a new position in shares of Danaher during the 3rd quarter valued at about $31,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Price Performance

Shares of NYSE:DHR opened at $198.20 on Thursday. The business has a 50 day moving average price of $199.69 and a 200 day moving average price of $214.77. Danaher Corporation has a twelve month low of $180.03 and a twelve month high of $242.80. The company has a market cap of $140.26 billion, a price-to-earnings ratio of 39.32, a PEG ratio of 2.69 and a beta of 0.95. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, topping analysts' consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. During the same quarter last year, the company earned $2.14 EPS. The company's quarterly revenue was up 4.6% on a year-over-year basis. Research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a $0.40 dividend. The ex-dividend date is Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. This is an increase from Danaher's previous quarterly dividend of $0.32. Danaher's dividend payout ratio is 31.75%.

Insider Activity at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the firm's stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 10.80% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on DHR. Wolfe Research lowered their price objective on Danaher from $260.00 to $230.00 and set an "outperform" rating on the stock in a report on Wednesday, April 8th. Guggenheim increased their target price on Danaher from $250.00 to $275.00 and gave the company a "buy" rating in a research note on Friday, January 2nd. Argus set a $265.00 target price on Danaher in a research note on Wednesday, January 14th. Evercore decreased their target price on Danaher from $254.00 to $225.00 and set an "outperform" rating for the company in a research note on Monday, April 6th. Finally, JPMorgan Chase & Co. increased their target price on Danaher from $270.00 to $275.00 and gave the company an "overweight" rating in a research note on Thursday, January 29th. Eighteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Danaher has a consensus rating of "Moderate Buy" and an average target price of $247.35.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.